To direct the Secretary of Defense to conduct a threat analysis of any potential threats the illicit fentanyl drug trade poses to the defense interests of the United States.
Latest Action
Referred to the House Committee on Armed Services.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™This bill, introduced in the 118th Congress as H.R. 9433, directs the Secretary of Defense to conduct a threat analysis regarding the potential risks posed by the illicit fentanyl drug trade to the defense interests of the United States. The bill aims to assess how the fentanyl trade could impact national security and military readiness. It was referred to the House Committee on Armed Services but ultimately failed or expired without further legislative action. No official summary or full text is available to provide more detailed provisions.
H.R. 9433 sought to have the Department of Defense analyze the national security threat from illicit fentanyl trafficking but did not advance beyond committee referral and expired.
- The bill mandates a threat analysis by the Secretary of Defense focused on illicit fentanyl's impact on U.S. defense interests.
- It was introduced in the House and referred to the House Committee on Armed Services.
- The bill did not progress and is recorded as failed or expired as of June 2025.
['Department of Defense, by receiving a formal assessment of fentanyl-related threats to defense interests', 'Policymakers and national security officials, through enhanced understanding of drug trade impacts', 'Potentially the broader public, if findings inform defense and security strategies']
['The bill does not specify funding or resources for conducting the threat analysis, which may affect implementation feasibility.', 'Lack of detailed provisions or oversight mechanisms in the available text could limit accountability or follow-up actions.', 'Without a full bill text, the scope and depth of the required analysis remain unclear.']
The bill was introduced in the House during the 118th Congress and referred to the House Committee on Armed Services. It addresses concerns about the national security implications of illicit fentanyl trafficking, a topic of interest in defense and public safety policy. However, the bill did not advance beyond committee referral and expired, indicating limited legislative momentum or prioritization.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['The threat analysis could inform future defense policy or resource allocation related to drug interdiction and national security.', 'Findings might influence interagency cooperation between defense, law enforcement, and public health sectors.', "Heightened awareness of fentanyl's impact on defense interests could lead to expanded legislative or executive actions."]
Transparency is limited by the absence of a full bill text and official summary, restricting detailed analysis. The lack of specified funding and oversight provisions suggests potential challenges in ensuring the mandated threat analysis is conducted thoroughly and reported effectively. Monitoring any future related legislation or Department of Defense actions would be important for accountability.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.